Medicines for HIV, viral hepatitis, and STIs in LMICs: forecasts of global demand for 2022-2026

Back to the "HIV and Co-Infections News" list

For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.

The World Health Organization released a report providing forecasts of future demand for medicines in low- and middle-income countries (LMICs) used in the fields of HIV, viral hepatitis and STIs. The report jointly presents medicines forecasts across three disease areas in recognition of the benefits of addressing HIV, viral hepatitis and STIs in a coordinated manner.

Access the report here.


Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?


Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.